Navigation Links
Stop-Smoking Drug May Also Curb Problem Drinking
Date:2/15/2012

By Denise Mann
HealthDay Reporter

WEDNESDAY, Feb. 15 (HealthDay News) -- The quit-smoking drug Chantix may also help problem drinkers cut their alcohol consumption, a small new study suggests.

Exactly how this drug curbs drinking is not fully understood, but its use may increase blood pressure, heart rate and feelings of sadness and nausea, thereby blunting the pleasurable effects of alcohol, the researchers said.

"Chantix might reduce alcohol consumption by reducing overall enjoyment of the alcohol drinking experience," said study author Emma Childs, a research associate at the University of Chicago.

"Chantix increased the unpleasant effects of alcohol, for example feeling drowsy and irritable, [and] participants also reported that they didn't like the alcohol effects as much," Childs said.

Approved to help smokers quit in 2006, Chantix (varenicline) has its share of potential side effects. In July 2009, the U.S. Food and Drug Administration mandated that Chantix carry a "black box" warning about the potential risks of depression and suicidal thoughts. Recently, the drug was linked to a small but significant risk of heart attack and stroke among people with pre-existing heart disease. Chantix costs roughly $3 per pill.

The results of the new study were released online in Alcoholism: Clinical & Experimental Research prior to publication in the May print issue.

The study included 15 healthy participants who took part in six sessions. They received a 2-mg dose of Chantix and an inactive placebo, followed three hours later by a beverage containing either a placebo, a low dose of alcohol, or a high dose of alcohol.

Before and after the sessions, the researchers asked the participants about their mood, tested visual ability and measured physiological responses such as blood pressure and heart rate.

The participants found the Chantix-booze combination increased the unpleasant effects of alcohol and reduced the rewarding aspects of drinking.

Whether the drug might someday be approved to help problem drinkers cut back remains to be seen, said the researchers, who acknowledged that the study's small size is a limitation.

"We are not currently performing any studies with Chantix, although other groups are actively pursuing this line of research with a view to developing Chantix as an aid to people wanting to quit or cut down their drinking," Childs said.

Dr. Ihsan Salloum, professor of psychiatry and director of the alcohol and drug abuse treatment program at the University of Miami Miller School of Medicine, termed the study encouraging.

Noting that new ways of treating alcoholism are much needed, Salloum said that Chantix may have a niche among smokers with alcohol-dependence issues. "We need a lot more options in terms of medicines to help curb drinking," he said. "We have many options for depression and need more for alcoholism, considering it is one of the most common diseases around the world."

More research is needed, he noted, but "this medication may be helpful for people with a drinking problem who are also smokers."

The study was funded by the U.S. National Institute on Drug Abuse and the U.S. National Institute on Alcohol Abuse and Alcoholism.

More information

Learn more about alcoholism and how it is treated at the U.S. National Institute on Alcohol Abuse and Alcoholism.

SOURCES: Ihsan Salloum, M.D., M.P.H., professor, psychiatry, and director, alcohol and drug abuse treatment program, University of Miami Miller School of Medicine; Emma Childs, Ph.D., research associate, University of Chicago; Feb. 16, 2012, Alcoholism: Clinical & Experimental Research, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Stop-Smoking Drug Chantix Ups Risk of Heart Problems: Study
2. Back Problems May Cut Into Retirement Savings
3. C-Sections Might Put Preemies at Risk for Breathing Problems
4. Cognitive problems common among non-demented elderly
5. Child Abuse, Neglect a Major Public Health Problem: CDC
6. People who retire early due to back problems face long-term financial disadvantage
7. Scientific plagiarism: A growing problem in an era of shrinking research funding
8. Hip Fracture Patients Often Have Other Health Problems
9. Many Head and Neck Cancer Survivors Face Eating Problems
10. Antidepressants While Pregnant Linked to Slight Risk of Lung Problem in Babies
11. Autism Gastro Problems May Be Linked to Gut Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stop-Smoking Drug May Also Curb Problem Drinking
(Date:4/26/2017)... Plano, TX (PRWEB) , ... April 26, 2017 ... ... to confer the distinction of Customer Excellence upon National Registry of Emergency ... , “Customer Engagement drives Financial Performance,” said Dr. Jan G. West, Ph.D. ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... today launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates how this advanced ... farmers produce more and better food, with fewer resources. It highlights the business’ ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... a breakthrough topical cream that’s the first in a new class of photodynamic ... the overall appearance of skin, visibly reduce outward signs of aging, and minimize ...
(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment ... can also decrease overall productivity and performance in the workplace. The goal of Clearview ... the last few weeks of April, Clearview Resolution Services will be shutting down the ...
(Date:4/25/2017)... ... 2017 , ... Lake Park Dental is now accepting new patients with crooked ... FL. With the help of this highly-effective, yet convenient system, patients can straighten their ... and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities ... to their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming ... provides an in-depth assessment of the current trends in ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., a ... drug prescribing process, today announced it closed $25 million in ... venture capital firm based in Seattle ... Venture Partners . The Series B round included participation from ... in 2014, and GV (formerly Google Ventures). As ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: